icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection. Results from the Treatment as Prevention for Hepatitis C (TrapHepC) program
 
 
  from Jules: its embarrassing that we in the USA are so far behind other countries like this France & Australia in starting real HCV elimination.
 
Reported by Jules Levin
EASL 2019 April 10-4 Vienna

0514191

Sigurdur Olafsson 1,2 , Ragnheidur H. Fridriksdottir1, Thorarinn Tyrfingsson3, Valgerdur Runarsdottir3, Ingunn Hansdottir3,4, Ottar M. Bergmann1, Einar S. Bjornsson1,2, Birgir Johannsson5, Bryndis Sigurdardottir5, Arthur Love2, 6,Gurún Erna Baldvinsdottir6 , Thorvardur J. Love2,7, Gudrun Sigmundsdottir8, Kamilla S. Josefsdottir8, Ubaldo Benitez Hernandez7, Maria Heimisdottir2, 9 , Magnus Gottfredsson2,5,7, and the TRAP HEP C working group
 
1Department of Gastroenterology and Hepatology, Landspitali University Hospital , 2Faculty of Medicine, School of Health Sciences, University of Iceland, 3SAA National Center for Addiction Medicine - Reykjavik Iceland, 4Faculty of Psychology, School of Health Sciences, University of Iceland, 5Department of Infectious Diseases, Landspitali University Hospital, 6Department of Virology, 7Department of Science, Landspitali University Hospital , 8Chief Epidemiologist, Directorate of Health, 9Department of Finance , Landspitali University Hospital, Reykavik, Iceland

0514192

0514193

0514194

0514195

0514196

0514197